Teladoc Health stock holds near USD 6.26 as revenue pressure persists

Published on 09/23/2026 at 12:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Teladoc Health stock traded at USD 6.26 on September 22, 2026, down 0.56 percent. Second-quarter revenue fell 4 percent year over year to USD 606.9 million.

TDOC, US87918A1051, Illustration mit AI erstellt.

Teladoc Health, Inc. (ISIN US87918A1051) traded at USD 6.26 on the NYSE on September 22, 2026, down USD 0.04, or 0.56 percent. The price sits within a 52-week range of USD 4.40 to USD 9.89, leaving the stock below its yearly high while the latest operating figures point to continuing revenue pressure.

Revenue falls to USD 606.9 million

Teladoc reported second-quarter 2026 revenue of USD 606.9 million, down 4 percent from the year-earlier period, according to MoneyDJ on September 23, 2026. The same report said revenue was 1.3 percent below analyst expectations, creating a quantified comparison between the reported result and consensus.

The latest quarterly earnings data were released on July 29, 2026. Teladoc reported a loss of USD 0.21 per share for that quarter, 4 cents better than the consensus estimate of a USD 0.25 loss, according to MarketBeat. The combination of a smaller-than-expected per-share loss and lower revenue places profitability and demand trends on different tracks.

Stock remains below yearly high

MarketBeat listed Teladoc at USD 6.26 on September 22, 2026, with a market capitalization of USD 1.14 billion and volume of 1.35 million shares. The 52-week high of USD 9.89 is USD 3.63 above that price, while the 52-week low of USD 4.40 is USD 1.86 below it.

The stock has also declined 10.1 percent since the beginning of 2026, when it traded at USD 6.98, according to MarketBeat. Its consensus price target is USD 7.54, based on five buy ratings, ten hold ratings and one sell rating in the cited overview.

Next quarterly date is October 28

MarketBeat lists October 28, 2026, as Teladoc's estimated next earnings date. That date gives the market a clear next checkpoint for assessing whether the 4 percent second-quarter revenue decline is narrowing or extending.

TDOC closes at USD 6.26

Teladoc Health stock closed at USD 6.26 on the NYSE on September 22, 2026, down 0.56 percent on the session. The company had a market capitalization of USD 1.14 billion as of the same market-data snapshot.